BiggsB Global · 30 years in regulated industries
Global regulatory, M&A and AI advisory.
For 30 years, BiggsB has supported organizations operating in regulated industries. Our experience includes global project management engagements for Roche, Pfizer and GSK. We combine global regulatory advisory with program delivery, validation and preclinical expertise, and support clients with mergers and acquisitions and AI regulation and governance.
- Practices
- Global regulatory · Mergers & acquisitions · AI regulation & governance
- Industries
- Life Sciences · Healthcare · Regulated Technology
- Engagements
- Advice and the execution that follows, led by senior practitioners
Selected pharmaceutical experience
BiggsB has delivered global project management engagements for Roche, Pfizer and GSK.
Global Program & Project ManagementExpertise
Three primary practices
- 01
Global Regulatory Advisory
BiggsB advises organizations on regulatory strategy across markets and carries out the work that follows: market-entry planning, submission support, regulatory intelligence, lifecycle obligations and remediation, coordinated across the jurisdictions in which a product or business operates.
- Regulatory strategy and market-entry planning across target markets
- Submission planning, preparation support and review
- Regulatory intelligence: monitoring changes and assessing their impact
- Lifecycle obligations: post-market requirements, changes and renewals
- 02
Mergers & Acquisitions in Regulated Industries
BiggsB supports acquirers, investors and sellers in regulated industries with regulatory, quality, operational and technology diligence, transaction risk assessment, integration planning and post-close execution.
- Buy-side and sell-side regulatory and quality diligence
- Operational and technology diligence, including validation status and data integrity
- Transaction risk assessment and remediation assumptions
- Integration planning for regulated operations, quality systems and computerized systems
- 03
AI Regulation & Governance
BiggsB helps regulated organizations determine which AI rules apply, assess and govern AI risk, and assure the AI-enabled systems they build or buy, with clear human accountability and ongoing monitoring.
- Regulatory applicability: which AI rules apply and in what role
- AI use-case inventory and risk assessment
- Governance: policy, roles, decision rights and accountability
- Model and system assurance: validation of AI-enabled systems
Supporting capabilities
Program delivery, validation and preclinical expertise that carry advice into execution, alongside quality, Veeva, leadership and diligence specialists.
Global Program & Project Management
Program oversight, PMO governance, portfolio optimization and performance management for complex regulated initiatives.Program & Project ManagementValidation & Assurance
Risk-based computer system validation and computer software assurance for GxP, cloud and AI-enabled systems, aligned to Part 11 and Annex 11.CSV & CSAPreclinical Development & Regulatory Support
Preclinical study design and oversight, readiness for first-in-human studies, and the IND and CTA submissions that follow.Preclinical & Clinical
Life Sciences
Pharmaceutical, biotech, medical device and diagnostics companies, and the clinical research organizations that support them, from development through submission, manufacturing and post-market obligations.
Healthcare
Healthcare organizations that handle patient data and adopt AI and digital services under privacy, security and clinical governance obligations.
Regulated Technology
Technology companies whose products are used in regulated settings, or are regulated themselves, and that must show customers, auditors and investors how their systems and AI are controlled.
Frameworks we work with
- United States — FDA and HHS frameworksIND and NDA support; 21 CFR Part 11; HIPAA
- European Union — EMA and EU frameworksCTA and MAA support; EU GMP Annex 11; EU AI Act; GDPR
- International standards and guidanceICH guidelines; GAMP 5 and computer software assurance principles; ISO/IEC 42001 and NIST AI RMF for AI governance
These describe service coverage, not office locations.
BiggsB Ventures
BiggsB Ventures Accelerator
BiggsB Ventures is a structured accelerator for founders building in regulated industries. It applies BiggsB's regulatory, quality and operating experience to early-stage companies so that product, regulatory path and commercial plan develop together.
Enabling technology
Our practitioners use regulatory technology to research and document faster: DAIN regulatory assistant, rEGS knowledge graph, RegForge. People remain accountable for the advice. How we use AI.
Speak with an advisor
Describe the decision or project in front of you. Your inquiry goes to the advisor team for the service you choose.